LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 1694 | 9876 | 11155 | 0.8854 | 0.8648 |
MCF 10A | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 9608 | 11155 | 0.8613 | 0.8365 |
MCF 10A | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 9945 | 11155 | 0.8915 | 0.8721 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11251 | 11155 | 1.0085 | 1.0101 |
MCF 10A | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 1694 | 10724 | 11155 | 0.9613 | 0.9544 |
MCF 10A | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11636 | 11155 | 1.0431 | 1.0508 |
MCF 10A | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 10440 | 11155 | 0.9359 | 0.9244 |
MCF 10A | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10887 | 11155 | 0.9760 | 0.9716 |
MCF 10A | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11792 | 11155 | 1.0570 | 1.0673 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 9752 | 11155 | 0.8742 | 0.8517 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 1694 | 1687 | 11155 | 0.1512 | -0.0008 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 1694 | 1599 | 11155 | 0.1433 | -0.0101 |
MCF 10A | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11362 | 11155 | 1.0186 | 1.0219 |
MCF 10A | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 4371 | 11155 | 0.3919 | 0.2830 |
MCF 10A | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 11259 | 11155 | 1.0093 | 1.0109 |
MCF 10A | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 10974 | 11155 | 0.9838 | 0.9808 |
MCF 10A | NU7441 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 11065 | 11155 | 0.9919 | 0.9905 |
MCF 10A | Dactolisib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 4098 | 11155 | 0.3674 | 0.2541 |
MCF 10A | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 9404 | 11155 | 0.8430 | 0.8149 |
MCF 10A | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 8038 | 11155 | 0.7206 | 0.6705 |
MCF 10A | PD0325901 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 3046 | 11155 | 0.2731 | 0.1429 |
MCF 10A | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 3039 | 11155 | 0.2725 | 0.1422 |
MCF 10A | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11343 | 11155 | 1.0168 | 1.0198 |
MCF 10A | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 5517 | 11155 | 0.4946 | 0.4040 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 5807 | 11155 | 0.5206 | 0.4347 |